2025 年全球关节内粘稠补充疗法市场报告

预计未来几年关节内粘稠补充疗法市场将快速成长。到 2029 年，这一数字将成长至 68.1 亿美元，复合年增长率为 10.6%。预测期内的成长可归因于监管支持、替代支付模式、增加医疗保健支出、研究和开发以及扩大适应症。预测期内的主要趋势包括基于结果的付费模式、病患教育计画、生物标记开发、基因治疗研究和基于价值的照护模式。

预计骨关节炎盛行率的不断上升将成为关节内粘稠补充疗法的主要动力。骨关节炎是一种进行性性关节疾病，也是常见的关节炎类型，其特征是关节破坏，特别是臀部、膝盖和手部关节破坏。关节内粘稠补充疗法包括将透明质酸直接注射到骨关节中，以缓解疼痛并使骨骼更容易活动。根据美国公共卫生服务机构疾病管制与预防中心 (CDC) 的数据，到 2040 年，关节炎预计将影响 7,840 万 18 岁及以上的美国成年人。这凸显了骨关节炎盛行率上昇在推动关节内粘稠补充疗法市场成长轨迹方面发挥的关键作用。

预计医疗保健支出的增加将推动未来几年关节内粘稠补充疗法的扩张。医疗保健支出是指医疗保健总支出，包括特定卫生系统或经济体中政府对医疗保健相关商品和服务的支出。医疗保健支出的快速成长在提高关节内粘稠补充疗法疗法的广泛采用和可及性方面发挥了关键作用。这种支持将涵盖研究、培训、基础设施开发和医疗保健计划覆盖等各个方面，最终使处理关节相关问题的个人受益。截至 2022 年 11 月，总部位于美国的非营利组织加拿大卫生资讯研究所报告医疗保健支出显着增加，2022 年将增加 0.8% 至 3,310 亿美元，而 2021 年为 7.6%。因此，医疗保健支出的成长趋势正在推动关节内粘稠补充疗法市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球关节内粘稠补充疗法市场 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
• 最终用途产业分析
• 全球关节内粘稠补充疗法市场：增长率分析
• 全球关节内粘稠补充疗法市场表现：规模与成长，2019 年至 2024 年
• 全球关节内粘稠补充疗法市场预测：规模与成长，2024-2029 年，2034 年
• 全球关节内粘稠补充疗法总目标市场 (TAM)

第六章 市场细分

• 全球关节内粘稠补充疗法市场类型、表现及预测，2019-2024 年、2024-2029 年、2034 年
• 单次注射关节内粘稠补充疗法
• 三次注射关节内粘稠补充疗法
• 五次注射关节内粘稠补充疗法
• 全球关节内粘稠补充疗法来源、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 鸟类起源
• 非鸟类起源
• 全球关节内粘稠补充疗法市场（按透明质酸、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 标准玻尿酸
• 稳定玻尿酸
• 全球关节内粘稠补充疗法市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 膝关节骨关节炎
• 髋关节骨关节炎
• 手部骨关节炎
• 全球关节内粘稠补充疗法市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 门诊手术中心
• 其他的
• 全球关节内粘稠补充疗法市场：单次注射关节内粘稠补充疗法细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 透明质酸类产品
• 不含玻尿酸的产品
• 全球关节内粘稠补充疗法市场：三种关节内粘稠补充疗法按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 透明质酸类产品
• 组合产品
• 全球关节内粘稠补充疗法市场：按类型、性能和预测对五种关节内粘稠补充疗法进行细分，2019-2024 年、2024-2029 年、2034 年
• 透明质酸类产品
• 组合产品

第七章 区域和国家分析

• 全球关节内粘稠补充疗法地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球关节内粘稠补充疗法市场（按国家/地区划分）、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 关节内粘稠补充疗法市场：竞争格局
• 关节内粘稠补充疗法市场：公司简介
  • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Aptissen SA
• Smith & Nephew Plc.
• Flexion Therapeutics Inc.
• Regen Lab SA
• OrthogenRx Inc.
• Fidia Farmaceutici SPA
• Ferring Pharmaceuticals
• Laboratoires VIVACY
• Allergan
• Hyalgan
• Synvisc
• Euflexxa
• Sanofi SA
• Wellchem Pharmaceuticals Pte Ltd.
• SingHealth Group

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年关节内粘稠补充疗法市场：提供新机会的国家
• 2029 年关节内粘稠补充疗法市场：提供新机会的细分市场
• 关节内粘稠补充疗法市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Viscosupplementation involves the injection of hyaluronic acid gel directly into the joint to alleviate friction during movement. Hyaluronic acid, naturally present in synovial fluid surrounding joints, aids in reducing friction during joint motion.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection methods. Single-injection viscosupplementation entails a direct injection of hyaluronic acid into the knee's diarthrodial joints, restoring the synovial fluid's rheological properties to generate anti-inflammatory and analgesic effects. Hyaluronic acid variations such as standard and stabilized forms, sourced from avian and non-avian origins, are used to address various osteoarthritic conditions such as knee, hip, and hand osteoarthritis. These treatments are administered across diverse healthcare settings, including hospitals, ambulatory surgical centers, among others.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends, and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.1 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to aging population, rising obesity rates, enhanced insurance coverage, growing awareness, patient preference, increased osteoarthritis cases.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to regulatory support, alternative payment models, increased healthcare expenditure, research and development, expansion of indications. Major trends in the forecast period include outcome-based payment models, patient education initiatives, biomarker development, gene therapy research, value-based care models.

The increasing prevalence of osteoarthritis is poised to be a significant driver for the viscosupplementation market in the foreseeable future. Osteoarthritis, a degenerative joint disease and a common form of arthritis, manifests in the breakdown of joints, particularly in areas such as the hips, knees, and hands. Viscosupplementation treatment, involving the direct injection of hyaluronic acid into bone joints, serves to alleviate pain and enhance smooth bone movement. According to the Centers for Disease Control and Prevention (CDC), an American public health service organization, a projected 78.4 million adults aged 18 years and older in the USA are expected to be afflicted by arthritis by the year 2040. This underscores the pivotal role of the rising prevalence of osteoarthritis in propelling the growth trajectory of the viscosupplementation market.

Anticipated growth in healthcare expenditure is set to foster the expansion of the viscosupplementation market in the coming years. Healthcare expenditure, denoting the total spending on healthcare costs, encompasses the financial outlay on healthcare-related goods and services within a specific healthcare system or economy. The surge in healthcare expenditure plays a pivotal role in advancing the broader adoption and increased accessibility of viscosupplementation. This support extends to various aspects, including research, training, infrastructure development, and coverage by healthcare plans, ultimately benefiting individuals grappling with joint-related issues. As of November 2022, the Canadian Institute for Health Information, a U.S.-based not-for-profit organization, reported a notable increase in healthcare expenditure to 0.8%, reaching $331 billion in 2022, compared to 7.6% in 2021. Consequently, the upward trajectory of healthcare expenditure emerges as a driving force behind the growth of the viscosupplementation market.

The viscosupplementation market is witnessing a surge in popularity driven by advancements in technology. Companies within this market are strategically embracing new technologies to maintain their competitive edge. In August 2021, Seikagaku Corporation, a prominent Japanese pharmaceutical firm, unveiled HyLink, an innovative viscosupplement designed for intra-articular single injection to address knee osteoarthritis. HyLink incorporates cross-linking technology, a method used to create a long-lasting cross-linked hyaluronate hydrogel that effectively persists in the joint cavity, establishing it as a durable treatment solution. This move reflects Seikagaku Corporation's commitment to staying at the forefront of technological developments within the viscosupplementation sector.

Leading companies in the viscosupplementation market are actively pursuing innovation to secure a competitive advantage. A notable example is Nuvo Pharmaceuticals Inc., a Canada-based pharmaceutical company, which, in January 2021, introduced NeoVisc+ 2 mL and NeoVisc ONE 4 mL in the Canadian market. These products are hyaluronic acid (HA) viscosupplements specifically designed to address pain relief and enhance joint functionality in patients with degenerative or mechanical arthropathy of the knee, commonly associated with osteoarthritis. The launch of NeoVisc+ 2 mL and NeoVisc ONE 4 mL underscores Nuvo Pharmaceuticals Inc.'s dedication to delivering cutting-edge treatment options for knee pain and osteoarthritis, contributing to the overall growth of the viscosupplementation market in Canada.

In December 2021, Avanos Medical Inc., a medical technology company based in the United States, successfully completed the acquisition of OrthogenRx Inc. for a total transaction value of $160 million. This strategic move significantly expanded, diversified, and enhanced Avanos Medical Inc.'s chronic pain product portfolio, specifically by incorporating treatment options for individuals with knee osteoarthritis. The acquisition was strategically aligned with the company's objective to fortify its partnerships with healthcare providers on a global scale, particularly in the realm of musculoskeletal pain treatment. OrthogenRx Inc., a U.S.-based medical device company with expertise in viscosupplementation therapies for knee osteoarthritis, played a pivotal role in reinforcing Avanos Medical Inc.'s position in this therapeutic space.

Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group

North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
• 2) By Source: Avian Origin; Non-Avian Origin
• 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
• 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
• 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
• 2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
• 3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
• Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Zimmer Biomet; Johnson & Johnson Services Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viscosupplementation Market Characteristics

3. Viscosupplementation Market Trends And Strategies

4. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Viscosupplementation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Viscosupplementation Market Growth Rate Analysis
• 5.4. Global Viscosupplementation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Viscosupplementation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Viscosupplementation Total Addressable Market (TAM)

6. Viscosupplementation Market Segmentation

• 6.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Injection Viscosupplementation
• Three Injection Viscosupplementation
• Five Injection Viscosupplementation
• 6.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Avian Origin
• Non-Avian Origin
• 6.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Hyaluronic Acid
• Stabilized Hyaluronic Acid
• 6.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Knee Osteoarthritis
• Hip Osteoarthritis
• Hand Osteoarthritis
• 6.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• 6.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyaluronic Acid-Based Products
• Non-Hyaluronic Acid Products
• 6.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyaluronic Acid-Based Products
• Combination Products
• 6.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyaluronic Acid-Based Products
• Combination Products

7. Viscosupplementation Market Regional And Country Analysis

• 7.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viscosupplementation Market

• 8.1. Asia-Pacific Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viscosupplementation Market

• 9.1. China Viscosupplementation Market Overview
• 9.2. China Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viscosupplementation Market

• 10.1. India Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viscosupplementation Market

• 11.1. Japan Viscosupplementation Market Overview
• 11.2. Japan Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viscosupplementation Market

• 12.1. Australia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viscosupplementation Market

• 13.1. Indonesia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viscosupplementation Market

• 14.1. South Korea Viscosupplementation Market Overview
• 14.2. South Korea Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viscosupplementation Market

• 15.1. Western Europe Viscosupplementation Market Overview
• 15.2. Western Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viscosupplementation Market

• 16.1. UK Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viscosupplementation Market

• 17.1. Germany Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viscosupplementation Market

• 18.1. France Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viscosupplementation Market

• 19.1. Italy Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viscosupplementation Market

• 20.1. Spain Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viscosupplementation Market

• 21.1. Eastern Europe Viscosupplementation Market Overview
• 21.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viscosupplementation Market

• 22.1. Russia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viscosupplementation Market

• 23.1. North America Viscosupplementation Market Overview
• 23.2. North America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viscosupplementation Market

• 24.1. USA Viscosupplementation Market Overview
• 24.2. USA Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viscosupplementation Market

• 25.1. Canada Viscosupplementation Market Overview
• 25.2. Canada Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viscosupplementation Market

• 26.1. South America Viscosupplementation Market Overview
• 26.2. South America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viscosupplementation Market

• 27.1. Brazil Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viscosupplementation Market

• 28.1. Middle East Viscosupplementation Market Overview
• 28.2. Middle East Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viscosupplementation Market

• 29.1. Africa Viscosupplementation Market Overview
• 29.2. Africa Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viscosupplementation Market Competitive Landscape And Company Profiles

• 30.1. Viscosupplementation Market Competitive Landscape
• 30.2. Viscosupplementation Market Company Profiles
  • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Viscosupplementation Market Other Major And Innovative Companies

• 31.1. Aptissen S.A.
• 31.2. Smith & Nephew Plc.
• 31.3. Flexion Therapeutics Inc.
• 31.4. Regen Lab SA
• 31.5. OrthogenRx Inc.
• 31.6. Fidia Farmaceutici S.P.A
• 31.7. Ferring Pharmaceuticals
• 31.8. Laboratoires VIVACY
• 31.9. Allergan
• 31.10. Hyalgan
• 31.11. Synvisc
• 31.12. Euflexxa
• 31.13. Sanofi S.A.
• 31.14. Wellchem Pharmaceuticals Pte Ltd.
• 31.15. SingHealth Group

32. Global Viscosupplementation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Market

34. Recent Developments In The Viscosupplementation Market

35. Viscosupplementation Market High Potential Countries, Segments and Strategies

• 35.1 Viscosupplementation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Viscosupplementation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Viscosupplementation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer